News Focus
News Focus
Followers 82
Posts 3771
Boards Moderated 0
Alias Born 08/08/2006

Re: Billcoln post# 662

Tuesday, 09/22/2009 12:35:36 PM

Tuesday, September 22, 2009 12:35:36 PM

Post# of 64905
I told my brother to give NPHC a serious look. I first discovered it at .32 and too wish someone had told me buy, buy at .02, but I'm happy where I'm at. Even at the current .67 (only .03 down from its new 52 week which occurred just this morning) this thing is a steal. This is an under a buck stock for a company due to release a game-changing stage 2 pain reliever with none of the side effects which have necessitated the canceling of once high-flying drugs like Merck's Vioxx (and the many lawsuits still pending), or new federal rules saying NSAID's and other pain relievers must contain warnings, such as addictiveness (not to be used for more than 3 days, etc), and other clinically proven side effects. The web site below says that the Fed will be imposing more warnings in the future. I'm happy to be on board at anything under a buck.

GLTA

http://www.fdalawblog.net/fda_law_blog_hyman_phelps/2009/05/new-labeling-required-for-otc-pain-relievers-and-fever-reducers-and-more-to-come.html

"A man's character is his fate." Heraclitus (c.540-c.480BC)

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NPHC News